Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

doi:10.1084/jem.182.5.1259

This Article

	Full Text (PDF, 558K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Cabrera, M.
	Articles by Blackwell, J. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Cabrera, M.
	Articles by Blackwell, J. M.


Social Bookmarking

	What's this?

ARTICLES

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

M Cabrera, MA Shaw, C Sharples, H Williams, M Castes, J Convit and JM Blackwell
Department of Medicine, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.

Recent studies have shown that mucocutaneous leishmaniasis (MCL), a severe and debilitating form of American cutaneous leishmaniasis (ACL) caused by Leishmania braziliensis infection, is accompanied by high circulating levels of tumor necrosis factor (TNF)-alpha. Analysis of TNF polymorphisms in Venezuelan ACL patients and endemic unaffected controls demonstrates a high relative risk (RR) of 7.5 (P < 0.001) of MCL disease in homozygotes for allele 2 of a polymorphism in intron 2 of the TNF-beta gene, especially in females (RR = 9.5; P < 0.001) compared with males (RR = 4; P < 0.05). A significantly higher frequency (P < 0.05) of allele 2 at the -308-basepair TNF-alpha gene polymorphism was also observed in MCL patients (0.18) compared with endemic control subjects (0.069), again associated with a high relative risk of disease (RR = 3.5; P < 0.05) even in the heterozygous condition. Because both the TNF-alpha and TNF-beta polymorphisms have previously been linked with functional differences in TNF-alpha levels, these data suggest that susceptibility to the mucocutaneous form of disease may be directly associated with regulatory polymorphisms affecting TNF-alpha production.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Forte, G. I., Scola, L., Misiano, G., Milano, S., Mansueto, P., Vitale, G., Bellanca, F., Sanacore, M., Vaccarino, L., Rini, G. B., Caruso, C., Cillari, E., Lio, D., Mansueto, S. (2009). Relevance of Gamma Interferon, Tumor Necrosis Factor Alpha, and Interleukin-10 Gene Polymorphisms to Susceptibility to Mediterranean Spotted Fever. CVI 16: 811-815 [Abstract] [Full Text]
Blackwell, J. M., Jamieson, S. E., Burgner, D. (2009). HLA and Infectious Diseases. Clin. Microbiol. Rev. 22: 370-385 [Abstract] [Full Text]
Maxwell, J. R., Potter, C., Hyrich, K. L., BRAGGSS, , Barton, A., Worthington, J., Isaacs, J. D., Morgan, A. W., Wilson, A. G. (2008). Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis. Hum Mol Genet 17: 3532-3538 [Abstract] [Full Text]
Carvalho, L. P., Pearce, E. J., Scott, P. (2008). Functional Dichotomy of Dendritic Cells following Interaction with Leishmania braziliensis: Infected Cells Produce High Levels of TNF-{alpha}, whereas Bystander Dendritic Cells Are Activated to Promote T Cell Responses. J. Immunol. 181: 6473-6480 [Abstract] [Full Text]
Baranska, M, Van Amelsvoort, L, Birindelli, S, Fustinoni, S, Corsini, E, Liesivuori, J, Van Loveren, H (2008). Association of pesticide exposure, vaccination response, and interleukin-1 gene polymorphisms. Hum Exp Toxicol 27: 709-713 [Abstract]
Zabaleta, J., Lin, H.-Y., Sierra, R. A., Hall, M.C., Clark, P. E., Sartor, O. A., Hu, J. J., Ochoa, A. C. (2008). Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis 29: 573-578 [Abstract] [Full Text]
Tosh, K., Ravikumar, M., Bell, J. T., Meisner, S., Hill, A. V.S., Pitchappan, R. (2006). Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India. Hum Mol Genet 15: 2880-2887 [Abstract] [Full Text]
Seidemann, K., Zimmermann, M., Book, M., Meyer, U., Burkhardt, B., Welte, K., Reiter, A., Stanulla, M. (2005). Tumor Necrosis Factor and Lymphotoxin Alfa Genetic Polymorphisms and Outcome in Pediatric Patients With Non-Hodgkin's Lymphoma: Results From Berlin-Frankfurt-Munster Trial NHL-BFM 95. JCO 23: 8414-8421 [Abstract] [Full Text]
Suriano, A. R., Sanford, A. N., Kim, N., Oh, M., Kennedy, S., Henderson, M. J., Dietzmann, K., Sullivan, K. E. (2005). GCF2/LRRFIP1 Represses Tumor Necrosis Factor Alpha Expression. Mol. Cell. Biol. 25: 9073-9081 [Abstract] [Full Text]
CASTELLUCCI, L., CHENG, L. H., ARAUJO, C., GUIMARAES, L. H., LESSA, H., MACHADO, P., ALMEIDA, M. F., OLIVEIRA, A., KO, A., JOHNSON, W. D., WILSON, M. E., CARVALHO, E. M., DE JESUS, A. R. (2005). FAMILIAL AGGREGATION OF MUCOSAL LEISHMANIASIS IN NORTHEAST BRAZIL. Am J Trop Med Hyg 73: 69-73 [Abstract] [Full Text]
Asghar, T., Yoshida, S., Kennedy, S., Negoro, K., Zhuo, W., Hamana, S., Motoyama, S., Nakago, S., Barlow, D., Maruo, T. (2004). The tumor necrosis factor-{alpha} promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 19: 2509-2514 [Abstract] [Full Text]
FITNESS, J., FLOYD, S., WARNDORFF, D. K., SICHALI, L., MWAUNGULU, L., CRAMPIN, A. C., FINE, P. E. M., HILL, A. V. S. (2004). LARGE-SCALE CANDIDATE GENE STUDY OF LEPROSY SUSCEPTIBILITY IN THE KARONGA DISTRICT OF NORTHERN MALAWI. Am J Trop Med Hyg 71: 330-340 [Abstract] [Full Text]
Eboumbou Moukoko, C., El Wali, N., Saeed, O. K., Mohamed-Ali, Q., Gaudart, J., Dessein, A. J., Chevillard, C. (2003). No Evidence for a Major Effect of Tumor Necrosis Factor Alpha Gene Polymorphisms in Periportal Fibrosis Caused by Schistosoma mansoni Infection. Infect. Immun. 71: 5456-5460 [Abstract] [Full Text]
AMATO, V. S., ANDRADE, H. F. JR., NETO, V. A., DUARTE, M. I. S. (2003). SHORT REPORT: PERSISTENCE OF TUMOR NECROSIS FACTOR-{alpha} IN SITU AFTER LESION HEALING IN MUCOSAL LEISHMANIASIS. Am J Trop Med Hyg 68: 527-528 [Abstract] [Full Text]
Sleijffers, A., Yucesoy, B., Kashon, M., Garssen, J., De Gruijl, F. R., Boland, G. J., Van Hattum, J., Luster, M. I., Van Loveren, H. (2003). Cytokine Polymorphisms Play a Role in Susceptibility to Ultraviolet B-Induced Modulation of Immune Responses after Hepatitis B Vaccination. J. Immunol. 170: 3423-3428 [Abstract] [Full Text]
Karplus, T. M., Jeronimo, S. M. B., Chang, H., Helms, B. K., Burns, T. L., Murray, J. C., Mitchell, A. A., Pugh, E. W., Braz, R. F. S., Bezerra, F. L., Wilson, M. E. (2002). Association between the Tumor Necrosis Factor Locus and the Clinical Outcome of Leishmania chagasi Infection. Infect. Immun. 70: 6919-6925 [Abstract] [Full Text]
Majetschak, M., Obertacke, U., Schade, F. U., Bardenheuer, M., Voggenreiter, G., Bloemeke, B., Heesen, M. (2002). Tumor Necrosis Factor Gene Polymorphisms, Leukocyte Function, and Sepsis Susceptibility in Blunt Trauma Patients. CVI 9: 1205-1211 [Abstract] [Full Text]
Freeman, B. D., Buchman, T. G., McGrath, S., Tabrizi, A. R., Zehnbauer, B. A. (2002). Template-Directed Dye-Terminator Incorporation with Fluorescence Polarization Detection for Analysis of Single Nucleotide Polymorphisms Implicated in Sepsis. J. Mol. Diagn. 4: 209-215 [Abstract] [Full Text]
Neben, K., Mytilineos, J., Moehler, T. M., Preiss, A., Kraemer, A., Ho, A. D., Opelz, G., Goldschmidt, H. (2002). Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 100: 2263-2265 [Abstract] [Full Text]
Libura, J., Bettens, F., Radkowski, A., Tiercy, J.M., Piguet, P.F. (2002). Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene. Eur Respir J 19: 912-918 [Abstract] [Full Text]
Grutters, J. C., Sato, H., Pantelidis, P., Lagan, A. L., McGrath, D. S., Lammers, J.-W. J., van den Bosch, J. M. M., Wells, A. U., du Bois, R. M., Welsh, K. I. (2002). Increased Frequency of the Uncommon Tumor Necrosis Factor -857T Allele in British and Dutch Patients with Sarcoidosis. Am. J. Respir. Crit. Care Med. 165: 1119-1124 [Abstract] [Full Text]
Kerr, A. R., Irvine, J. J., Search, J. J., Gingles, N. A., Kadioglu, A., Andrew, P. W., McPheat, W. L., Booth, C. G., Mitchell, Tim. J. (2002). Role of Inflammatory Mediators in Resistance and Susceptibility to Pneumococcal Infection. Infect. Immun. 70: 1547-1557 [Abstract] [Full Text]
Pirmohamed, M., Lin, K., Chadwick, D., Park, B. K. (2001). TNF{{alpha}} promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology 56: 890-896 [Abstract] [Full Text]
Yamaguchi, E., Itoh, A., Hizawa, N., Kawakami, Y. (2001). The Gene Polymorphism of Tumor Necrosis Factor-{beta}, But Not That of Tumor Necrosis Factor-{{alpha}}, Is Associated With the Prognosis of Sarcoidosis. Chest 119: 753-761 [Abstract] [Full Text]
Rudwaleit, M, Siegert, S, Yin, Z, Eick, J, Thiel, A, Radbruch, A, Sieper, J, Braun, J (2001). Low T cell production of TNF{alpha} and IFN{gamma} in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60: 36-42 [Abstract] [Full Text]
Kwiatkowski, D. (2000). Science, medicine, and the future: Susceptibility to infection. BMJ 321: 1061-1065 [Full Text]
Roberts, L. J, Handman, E., Foote, S. J (2000). Science, medicine, and the future: Leishmaniasis. BMJ 321: 801-804 [Full Text]
Mira, J.-P., Cariou, A., Grall, F., Delclaux, C., Losser, M.-R., Heshmati, F., Cheval, C., Monchi, M., Teboul, J.-L., Riche, F., Leleu, G., Arbibe, L., Mignon, A., Delpech, M., Dhainaut, J.-F. (1999). Association of TNF2, a TNF-{alpha} Promoter Polymorphism, With Septic Shock Susceptibility and Mortality: A Multicenter Study. JAMA 282: 561-568 [Abstract] [Full Text]
Kumar, A., Short, J., Parrillo, J. E. (1999). Genetic Factors in Septic Shock. JAMA 282: 579-581 [Full Text]
Milner, C.R., Craig, J.E., Hussey, N.D., Norman, R.J. (1999). No association between the �308 polymorphism in the tumour necrosis factor {alpha} (TNF{alpha}) promoter region and polycystic ovaries. Mol Hum Reprod 5: 5-9 [Abstract] [Full Text]
Gorivodsky, M., Zemlyak, I., Orenstein, H., Savion, S., Fein, A., Torchinsky, A., Toder, V. (1998). TNF-{alpha} Messenger RNA and Protein Expression in the Uteroplacental Unit of Mice with Pregnancy Loss. J. Immunol. 160: 4280-4288 [Abstract] [Full Text]
Weatherall, D., Clegg, J., Kwiatkowski, D. (1997). The Role of Genomics in Studying Genetic Susceptibility to Infectious�Disease. Genome Res 7: 967-973 [Full Text]
Turbay, D., Lieberman, J., Alper, C. A., Delgado, J. C., Corzo, D., Yunis, J. J., Yunis, E. J. (1997). Tumor Necrosis Factor Constellation Polymorphism and Clozapine-Induced Agranulocytosis in Two Different Ethnic Groups. Blood 89: 4167-4174 [Abstract] [Full Text]
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., Duff, G. W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha �promoter on transcriptional�activation. Proc. Natl. Acad. Sci. USA 94: 3195-3199 [Abstract] [Full Text]
Christou, N. V. (1996). Host Defense Mechanisms of Surgical Patients: Friend or Foe?. Arch Surg 131: 1136-1140 [Abstract]